Syndicate content The Healthcare Sales & Marketing Network
Healthcare Sales & Marketing Network NewsFeed
Updated: 3 min 58 sec ago

Cook Medical Enrolls First Patient in Zilver(R) PTX(R) Drug Eluting Peripheral Stent Clinical Study in China

Fri, 08/15/2014 - 12:54
BLOOMINGTON, Ind.--(Healthcare Sales & Marketing Network)--Cook Medical has enrolled the first patient in the clinical study in China of its Zilver® PTX® Drug Eluting Peripheral Stent. The case was performed by one of the study’s principal investig...
Devices, Interventional
Cook Medical, Zilver PTX, drug eluting stent, peripheral artery disease

Innovus Pharma and Consortia Health Initiate a Nationwide Marketing and Sales Campaign to U.S. Gynecologists for Zestra(R), Clinically Proven for the Enhancement of Female Arousal Desire and Satisfaction

Fri, 08/15/2014 - 12:48
SAN DIEGO, Aug. 15, 2014 -- (Healthcare Sales & Marketing Network) -- Innovus Pharmaceuticals, Inc., ("Innovus Pharma" or the "Company) (INNV) a leader in over-the-counter ("OTC") and consumer care products fo...
Innovus Pharmaceuticals, Consortia Health, Zestra

FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer

Thu, 08/14/2014 - 21:19
Avastin is the first biologic medicine approved in combination with chemotherapy to help women with this type of cancer live longer than with chemotherapy alone SOUTH SAN FRANCISCO, Calif.--(Healthcare Sales & Marketing Network)--Genentech, a member of ...
Biopharmaceuticals, Oncology, FDA
Genentech, Roche Group, Avastin, bevacizumab, Cervical Cancer

Vermillion Announces Additions to Commercial Management Team

Thu, 08/14/2014 - 13:33
AUSTIN, Texas, Aug. 14, 2014 -- (Healthcare Sales & Marketing Network) -- Vermillion, Inc. (VRML), a multivariate diagnostics company focused on gynecologic cancers and women's health, has appointed David Jansen as Vice President of Marketing. In addition...
Diagnostics, Personnel

Aurora Spine Appoints Regional Vice President of Sales

Thu, 08/14/2014 - 13:29
CARLSBAD, CALIFORNIA--(Healthcare Sales & Marketing Network) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the appointment of Joe Bocchino as Regional Vice President of Sales for the Western United States. Mr. Bocchino will be responsible fo...
Devices, Orthopaedic, Neurosurgery, Personnel
Aurora Spine, spine surgery

Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals

Thu, 08/14/2014 - 13:24
Adds Four Additional Fully-Funded Programs to Partnered Portfolio SAN DIEGO--(Healthcare Sales & Marketing Network)--Ligand Pharmaceuticals Incorporated (LGND) announces the signing of a commercial license agreement with Avion Pharmaceuticals, LLC for t...
Biopharmaceuticals, Licensing
Ligand Pharmaceuticals, Avion Pharmaceuticals, Captisol

Inotek Pharmaceuticals Names David P. Southwell as President and Chief Executive Officer

Wed, 08/13/2014 - 20:41
LEXINGTON, Mass.--(Healthcare Sales & Marketing Network)--Inotek Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on ophthalmology, today announced that David. P. Southwell has been named President and Chief Executive Officer. Mr. ...
Biopharmaceuticals, Ophthalmology, Personnel
Inotek Pharmaceuticals, Trabodenoson

Tarsa Therapeutics Secures $10 Million And Adds Industry Veteran Daniel Soland As A Director

Wed, 08/13/2014 - 20:30
PHILADELPHIA, Aug. 13, 2014 -- (Healthcare Sales & Marketing Network) -- Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds t...
Biopharmaceuticals, Venture Capital, Personnel
Tarsa Therapeutics, Ostora , calcitonin

Castle Biosciences Announces $11.8 Million Financing

Wed, 08/13/2014 - 20:23
Led by New Investor HealthQuest Capital Funds to Expand Clinical Availability of Cutaneous Melanoma Gene Expression Profile Test FRIENDSWOOD, Texas--(Healthcare Sales & Marketing Network)--Castle Biosciences Inc., a cancer-focused molecular diagnosti...
Diagnostics, Venture Capital
Castle Biosciences, DecisionDx-Melanoma

Seventh Sense Biosystems Closes $16 Million Series B Financing

Wed, 08/13/2014 - 11:39
New Investors Siemens, Novartis and LabCorp® Join Polaris Partners and Flagship Ventures to Fund Development and Launch of Patented Touch Activated Phlebotomy (TAP™) Blood Collection and Testing Platforms CAMBRIDGE, Mass.--(Healthcare Sales & Market...
Devices, Diagnostics, Venture Capital
Seventh Sense Biosystems, Touch Activated Phlebotomy

Cutera Receives FDA 510(k) Clearance for enlighten(TM)

Tue, 08/12/2014 - 12:57
First and Only FDA-Cleared Dual Wavelength and Dual Pulse Duration Laser Featuring Picosecond Technology BRISBANE, Calif., Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Cutera, Inc. (CUTR), a leading provider of laser, light and other energ...
Devices, Dermatology, FDA
Cutera, enlighten laser, picosecond

AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer

Tue, 08/12/2014 - 12:53
WALTHAM, Mass., Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- AMAG Pharmaceuticals, Inc. (AMAG) today announced the appointment of Robert Blood, Esq. as vice president of legal affairs and chief compliance officer. Mr. Blood comes to AMAG with...
Biopharmaceuticals, Personnel
AMAG Pharmaceuticals

FDA Approves Exact Sciences' Cologuard(R); First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test

Tue, 08/12/2014 - 12:50
First time in history a technology receives FDA approval and proposed national coverage by CMS on the same day Screening test detects 92% of colorectal cancer MADISON, Wis., Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Exact Sciences C...
Diagnostics, Oncology, FDA
Exact Sciences, Cologuard, colorectal cancer

Lithera Announces Company Name Change to Neothetics, Inc.

Tue, 08/12/2014 - 12:43
SAN DIEGO, Aug. 12, 2014 -- (Healthcare Sales & Marketing Network) -- Lithera, Inc., announced today that it has changed its name to Neothetics, Inc. The new name strengthens the company's positioning as a clinical-stage, specialty pharmaceutical company d...
Biopharmaceuticals, Dermatology
Neothetics, Lithera , aesthetic

Cortendo AB: First Patient Enrolled into NormoCort Phase 3 SONICS Trial Following a Successful EU Investigator Meeting

Tue, 08/12/2014 - 12:38
Continued Progress On Trial Implementation GÖTEBORG, Sweden.--(Healthcare Sales & Marketing Network)--Cortendo AB (OSE:CORT) today announced that the first patient has been enrolled into the Phase 3 SONICS trial, i.e., “Study Of NormoCort In Cushin...
Cortendo AB, SONICS trial, NormoCort, Cushing’s Syndrome

Mylan Launches Generic Xeloda(R) Tablets

Mon, 08/11/2014 - 16:21
PITTSBURGH, Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Mylan Inc. (MYL) today announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda® Tablets. Mylan received final approval...
Biopharmaceuticals, Generics, FDA, Product Launch
Mylan, Genentech, Xeloda, Capecitabine

Sanofi and MannKind Announce Global Licensing Agreement for Afrezza(R) (insulin human) Rapid-Acting Inhaled Insulin

Mon, 08/11/2014 - 16:19
PARIS and VALENCIA, Calif., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Sanofi (EURONEXT: SAN and NYSE: SNY) and MannKind Corporation (MNKD) announced today that they have entered into a worldwide exclusive licensing agreement for developme...
Biopharmaceuticals, Endocrinology, Drug Delivery, Licensing
Sanofi, MannKind, Afrezza, insulin

Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer

Mon, 08/11/2014 - 16:14
CHESTERBROOK, Pa., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Auxilium Pharmaceuticals, Inc. (AUXL), a fully integrated specialty biopharmaceutical company, announced that Andrew Saik will be appointed Chief Financial Officer, effective Au...
Biopharmaceuticals, Personnel
Auxilium Pharmaceuticals, XIAFLEX

Niklas Prager Appointed New President and CEO of Medivir

Mon, 08/11/2014 - 12:59
STOCKHOLM--(Healthcare Sales & Marketing Network)--Medivir AB (MVIR-B.ST) today announces that the company’s Board of Directors has appointed Niklas Prager as new President and CEO of Medivir AB effective 1 September 2014. Niklas Prager will succeed Maris ...
Biopharmaceuticals, Personnel
Medivir AB

EYLEA(R) (aflibercept) Injection Receives EU Approval for the Treatment of Diabetic Macular Edema (DME)

Mon, 08/11/2014 - 12:38
TARRYTOWN, N.Y., Aug. 11, 2014 -- (Healthcare Sales & Marketing Network) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual imp...
Biopharmaceuticals, Ophthalmology, Regulatory
Regeneron Pharmaceuticals, EYLEA, aflibercept, Diabetic Macular Edema

Contact us     New York    l    Miami    l    Sao Paulo     l    Mexico DF    l    London    l    Hong Kong